Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months

NCT00755833 · clinicaltrials.gov ↗

COMPLETED

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart 50

Sponsor

Novo Nordisk A/S